Maternal Vaccination for the Prevention of Infantile RSV Disease: An Overview of the Authorized, In-Progress, and Rejected Vaccine Candidates

Respiratory Syncytial Virus (RSV) continues to pose a significant challenge, contributing to elevated hospitalization rates among children up to 5 years old, with a disproportionate burden on newborns and infants under 6 months old. The unique characteristics of the young immune system make it prone...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Georgios Papazisis, Xanthippi Topalidou
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2024-08-01
Schriftenreihe:	Vaccines
Schlagworte:	infant immunity maternal antibody transfer respiratory syncytial virus maternal immunization RSV vaccine clinical trial
Online-Zugang:	https://www.mdpi.com/2076-393X/12/9/980
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!